Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non–ST-Elevation Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non–ST-Elevation Acute Coronary Syndrome

Published:2015-09 Issue:5 Volume:116 Page:809-817
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bavishi Chirag^ORCID,Panwar Sadik,Messerli Franz H.,Bangalore Sripal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

2. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

3. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

4. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity;Gurbel;Circulation,2003

5. Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease;Wallentin;Eur Heart J,2008

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinical Outcomes in Acute Coronary Syndrome Patients Who Undergo Percutaneous Coronary Intervention Using Different P2Y12 Inhibitors: A SMS Hospital Based Observational Study;2023-12-05

2. An eco-friendly ultra-performance liquid chromatography–mass spectrometry method for quantification of rivaroxaban and ticagrelor in rat plasma: grapefruit interactions;Bioanalysis;2023-11

3. Outcomes of same‐day discharge following percutaneous coronary intervention in a rural population;Catheterization and Cardiovascular Interventions;2023-07-22

4. P2Y12 Inhibitors for Non–ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis;Texas Heart Institute Journal;2023-05-01

5. Pharmacoeconomic analysis of personalized antiplatelet therapy in patients with acute coronary syndromer;Pharmacogenetics and Pharmacogenomics;2023-02-27